Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
about
Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapyClinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataPolymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan ChildrenGenetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum ParasitesBaseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control.Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular AssaysExamining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionPrevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda.Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia.Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children.Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in UgandaMalaria parasite clearance.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Arteether resistance reversal by ketoconazole/fluconazole in rodent malaria parasite Plasmodium vinckei.Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial.High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, TanzaniaThe impact of packaging and messaging on adherence to malaria treatment: Evidence from a randomized controlled trial in UgandaMalaria parasite clearance from patients following artemisinin-based combination therapy in Côte d'Ivoire
P2860
Q26209187-19B09703-701D-459A-8FBC-2C983039CF27Q26783902-607A0688-1924-42EB-8AA6-7359BCC50D46Q27861962-6A84B233-9986-4B8B-B355-5D77E68967F9Q28554000-98C10458-0F71-44DF-9832-8D30F212989EQ30995133-D58879EA-A256-499F-954C-3F9D227CA3C0Q33662226-3D59E63F-9C48-4C13-A361-68306875CEA1Q35097323-79143421-7481-4528-B123-90D77213DF87Q35590729-92B4B023-32FE-486A-B224-B1B2A510E735Q35607844-5DF0F6BF-0463-4AF8-AA46-29CAD07E3932Q35860091-D4072C1B-E83A-4FE8-8226-041FF6BC4FF4Q35991544-7CA5F951-3F5A-44C1-B8C2-1AE2E4AFBE3DQ36108352-5A05F75F-B536-43B0-BA5B-7D5FCEA5934AQ36138583-F9D5FC0A-695A-4CA2-BEC9-6F2916495CE0Q36776118-50062B39-52F6-4125-B1C2-3DEEE469CC53Q37003081-2DB6F8AD-C7BF-4EDA-98FF-615565EF6016Q37287899-C860BCEB-1D34-418E-AF92-BBBAF1C1C909Q37517983-92FE230D-AAD5-4F58-ADD7-08DA247937C4Q37576425-01FA6FC1-6C77-4BBF-A118-B6E9A362FBC9Q37663369-A1D53655-2DC2-4C84-B83D-DF8E53F90DB3Q38529669-4141AE26-79F5-4260-817A-DE142176A8E5Q38642887-6318BD25-3AE6-4912-87FA-B5D6C3E6316DQ41524884-1ACF946F-B949-4A53-B0E2-0BA7630490A0Q47107926-49C73B09-3747-4567-BFA2-C04089253E73Q56363463-68A751BC-A23E-439C-BACD-C2C2B9E44D83Q56909788-EF651664-9074-4AB6-ABDC-C11474532C33Q59126227-1AACEB84-5E1B-4747-9014-7ACA3C567FAE
P2860
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early parasite clearance follo ...... Plasmodium falciparum malaria
@en
Early parasite clearance follo ...... Plasmodium falciparum malaria.
@nl
type
label
Early parasite clearance follo ...... Plasmodium falciparum malaria
@en
Early parasite clearance follo ...... Plasmodium falciparum malaria.
@nl
prefLabel
Early parasite clearance follo ...... Plasmodium falciparum malaria
@en
Early parasite clearance follo ...... Plasmodium falciparum malaria.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Early parasite clearance follo ...... Plasmodium falciparum malaria
@en
P2093
Abel Kakuru
Ambrose Talisuna
Emmanuel Osilo
Francis Orukan
Frank Kaharuza
Mary K Muhindo
Prasanna Jagannathan
P2860
P2888
P356
10.1186/1475-2875-13-32
P577
2014-01-28T00:00:00Z
P5875
P6179
1006125938